164O Health-related quality of life (HRQoL) with pembrolizumab (pembro) + chemotherapy (chemo) vs placebo (pbo) + chemo as 1L treatment for advanced triple-negative breast cancer (TNBC): Results from KEYNOTE-355
Makaleler > Tam Makale · 2022
Yazarlar: D.W. Cescon, P. Schmid, H.S. Rugo, S-A. Im, M. Md Yusof, C.E. Gallardo, O. Lipatov, C.H. Barrios, J.M. Perez Garcia, H. Iwata, N. Masuda, M.A. Torregroza Otero, Erhan GÖKMEN, S. Loi, A. Haiderali, X. Zhou, Z. Guo, A. Martin Nguyen, J. Cortés
Annals of Oncology, Uluslararası, Wos, 2022, cilt 33, ss S197-S198